Search
for

    Sort by

    Research 481–510 of 1000+

    1. BIOLOGICAL ACTIVITY OF ANTIANDROGENS 1970 · 51 citations
    2. Selective non-steroidal inhibitors of 5α-reductase type 1 2004 · 49 citations
    3. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    4. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    5. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    6. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    7. Finasteride for prostatic disease: an updated and comprehensive review Expert opinion on drug metabolism & toxicology · 2008 · 14 citations
    8. New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide) Steroids · 2005 · 14 citations
    9. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    10. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist Tetrahedron Letters · 1994 · 14 citations
    11. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    12. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    13. Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens Journal of Medicinal Chemistry · 1995 · 12 citations
    14. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    15. COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE? Endocrinology · 1991 · 9 citations
    16. Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data Interdisciplinary sciences: computational life sciences · 2018 · 5 citations
    17. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS Archivio italiano di urologia, andrologia · 2013 · 4 citations
    18. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    19. Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model International Journal of Preventive Medicine and Health (IJPMH) · 2023 · 2 citations
    20. The search for bioactive compounds in tropical plants to target hormone imbalance associated diseases edoc (University of Basel) · 2007 · 2 citations
    21. Crystal Structure and Synthesis of 17α-Hexanoyloxy-16β-methylpregna-4,6-diene-3,20-dione Analytical Sciences · 2001 · 2 citations
    22. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations
    23. Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione X-ray Structure Analysis Online · 2009 · 1 citations
    24. Editorial comment The Journal of Urology · 2005 · 1 citations
    25. The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis World Journal of Urology · 2026
    26. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of Springer Link (Chiba Institute of Technology) · 2026
    27. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models E3S Web of Conferences · 2026
    28. MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS The Journal of Urology · 2025
    29. MP09-17 METHYLATION OF SRD5A2 IN THE BLOOD AS A NOVEL BIOMARKER TO PREDICT SENSITIVITY TO 5-ARI TREATMENT 2024
    30. Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands Pharmaceutical Sciences · 2021